Coherus Oncology, Inc. Common Stock
CHRS
CHRS
174 hedge funds and large institutions have $744M invested in Coherus Oncology, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 69 increasing their positions, 59 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
-2
Holders Change %
-1.14%
% of All Funds
3.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
69
Reduced
59
Closed
23
Calls
$4K
Puts
$679K
Net Calls
-$675K
Net Calls Change
-$3.34M